Cited by 37Adipokines, Inflammation, and Metabolic DiseasesObesity, Physical Activity, DietCardiovascular Disease and Adiposity

Circulating osteonectin and adipokine profiles in relation to metabolically healthy obesity in Chinese children: Findings from BCAMS

Open access
Fu, Junling, Li, Yu, Esangbedo, Issy C., Li, Ge, Feng, Dan, Li, Lujiao, Xu, Lu, Han, Lanwen +5 more·2018·Journal of the American Heart Association

Abstract

Background The role of adipokine dysregulation in determining the metabolic fate of obesity is not well studied. We aimed to examine whether the matricellular protein osteonectin and the profiles of certain adipokines could differentiate metabolically healthy obese ( MHO ) versus metabolically unhealthy obese phenotypes in childhood. Methods and Results This study included 1137 obese children and 982 normal-weight healthy ( NWH ) controls recruited from the BCAMS (Beijing Child and Adolescent Metabolic Syndrome) study. MHO was defined by the absence of insulin resistance and/or any metabolic syndrome components. Six adipokines-osteonectin, leptin, adiponectin, resistin, FGF21 (fibroblast growth factor 21), and RBP-4 (retinol binding protein 4)-were assessed. Approximately 20% of obese children displayed the MHO phenotype. MHO children had a more favorable adipokine profile than metabolically unhealthy obese children, with lower osteonectin, leptin, and RBP -4 and higher adiponectin (all P<0.05). Compared with normal-weight healthy controls, MHO children displayed increased leptin, resistin, and RBP -4 levels and reduced adiponectin concentrations (all P<0.05) but similar osteonectin and FGF 21 levels. Among obese subjects, decreased osteonectin (odds ratio [OR]: 0.82; 95% confidence interval [CI] per standard deviation, 0.70-0.97), RBP -4 (OR: 0.77; 95% CI per standard deviation, 0.64-0.93), and leptin/adiponectin ratio (OR: 0.58; 95% CI per standard deviation, 0.43-0.77) were independent predictors of MHO . In addition, compared with children without abnormalities, those with any 3 adipokine abnormalities were 80% less likely to exhibit the MHO phenotype ( OR : 0.20; 95% CI , 0.10-0.43) and 3 times more likely to have metabolic syndrome ( OR : 2.77; 95% CI , 1.52-5.03). Conclusions These findings suggest that dysregulation of adipokines might govern the metabolic consequences of obesity in children. Low osteonectin levels, along with a healthy adipokine profile, might be used as an early marker of the MHO phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.118.009169

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibition of adipogenesis can restrict storage of triglycerides in adipose tissue, increasing circulating levels (systemic hyperlipidemia) and lipid deposition in liver and skeletal muscle.

    “Therefore, the inhibition of adipogenesis can restrict the storage of triglycerides in tissue adipose, increasing circulating levels (systemic hyperlipidemia) and lipid deposition in the liver and skeletal muscle [55].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 58 · Cited by 37

Research works printed but not linked: 1

  1. [3]Samocha‐Bonet D, Dixit VD, Kahn CR, Leibel RL, Lin X, Nieuwdorp M, Pietilainen KH, Rabasa‐Lhoret R, Roden M, Scherer PE, Klein S, Ravussin E. Metabolically healthy and unhealthy obese—the 2013 Stock Conference report. Obes Rev. 2014; 15: 697– 708. 25059108 PMC4519075

Authors
Fu, J., Li, Y., Esangbedo, I. C., Li, G., Feng, D., Li, L., Xu, L., Han, L., Li, M., Li, C., Gao, S., Li, M., & Willi, S. M.
Affiliations
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Children's Hospital of Philadelphia (US)
  • Capital Medical University (CN)
Corresponding author
Li, Ming
Venue
Journal of the American Heart Association
Published
2018-12-04
Volume
7
Issue
23
Pages
e009169-e009169
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2901168594
Cited by
37
References
58
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 9 · 2022: 3 · 2021: 4 · 2020: 8 · 2019: 3
FWCI
2.93
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of the American Heart Association (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
metabolically healthy obesity, childhood obesity, SPARC, adipokines, leptin, adiponectin, resistin, FGF21, retinol-binding protein 4, metabolic syndrome, insulin resistance, matricellular proteins, Chinese children, leptin/adiponectin ratio, obesity phenotypes, adipose tissue inflammation, adipose tissue fibrosis
MeSH terms
Obesity, Metabolically Benign, Adolescent, Child, Female, Fibroblast Growth Factors, Humans, Male, Osteonectin, Case-Control Studies, Leptin, Adiponectin, Resistin, Adipokines, Retinol-Binding Proteins, Plasma, Pediatric Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review